Ćwiek Aleksandra
II Psychiatric Department, Institute of Psychiatry and Neurology, Warsaw, Poland.
Postep Psychiatr Neurol. 2024 Jun;33(2):98-102. doi: 10.5114/ppn.2024.141377. Epub 2024 Jul 10.
An overview of the current pharmacological treatment and psychosocial interventions, such as cognitive-behavioral therapy and breathing exercises, for depression and anxiety among hemodialyzed patients (HD).
Depression and anxiety are common problems among HD patients, influencing their mortality and morbidity; however, they are often under-recognized and under-treated. Even though the topic is attracting more scientific attention there are still only few studies about methods of treatment for those disorders. Moreover, there are no clear guidelines on pharmacological therapy, which may prove to be difficult among patients with decreased renal function. Psychological interventions such as cognitive-behavioral therapy may be useful in treatment of these mental disorders among HD patients, though reports on the effects of such interventions are scarce.
This review outlines some of the current approaches to the treatment of mental disorders among HD patients that use both antidepressants and therapeutic methods. There is an urgent need for randomized clinical trials of both psychosocial and pharmacological interventions in treatment of depressive and anxiety disorders. Currently, both methods seem to be useful; however, they should be implemented with caution until clear guidelines are developed.
概述目前针对血液透析患者(HD)抑郁和焦虑的药物治疗及心理社会干预措施,如认知行为疗法和呼吸练习。
抑郁和焦虑是血液透析患者中的常见问题,影响其死亡率和发病率;然而,它们常常未得到充分认识和治疗。尽管该主题正吸引更多科学关注,但关于这些病症治疗方法的研究仍然很少。此外,在药物治疗方面没有明确的指南,这对于肾功能减退的患者可能会有困难。诸如认知行为疗法等心理干预措施可能对血液透析患者的这些精神障碍治疗有用,不过关于此类干预效果的报告很少。
本综述概述了目前治疗血液透析患者精神障碍的一些方法,这些方法同时使用抗抑郁药和治疗手段。迫切需要针对抑郁和焦虑症治疗的心理社会和药物干预进行随机临床试验。目前,这两种方法似乎都有用;然而,在制定明确指南之前应谨慎实施。